Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Personalised Irradiation With Rhenium-Skin Cancer Therapy (SCT) for the Treatment of Non-Melanoma Skin Cancer: A Phase IV, Multi-Centre, International, Open-Label, Single Arm Study.

NCT05135052 is registered in ClinicalTrials.gov with OncoBeta Therapeutics as lead sponsor.

NCT NCT05135052
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05135052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Personalised Irradiation With Rhenium-Skin Cancer Therapy (SCT) for the Treatment of Non-Melanoma Skin Cancer: A Phase IV, Multi-Centre, International, Open-Label, Single Arm Study.
Lead sponsor
OncoBeta Therapeutics
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 17, 2022
Completion date
May 15, 2027
Enrollment
210 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

non-melanoma skin cancer